MedPath

北京吉洛华制药有限公司

Ownership
-
Established
1998-05-19
Employees
-
Market Cap
-
Website
www.jnovapharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

12

NMPA:12

Drug Approvals

Linezolid and Glucose Injection

Product Name
利奈唑胺葡萄糖注射液
Approval Number
国药准字H20254164
Approval Date
May 13, 2025
NMPA

Teicoplanin for Injection

Product Name
注射用替考拉宁
Approval Number
国药准字H20253100
Approval Date
Jan 8, 2025
NMPA

Isepamicin Sulfate Injection

Product Name
硫酸异帕米星注射液
Approval Number
国药准字H20249397
Approval Date
Nov 15, 2024
NMPA

Levofloxacin and Sodium Chloride Injection

Product Name
可乐必妥
Approval Number
国药准字H20103722
Approval Date
Nov 13, 2020
NMPA

Levofloxacin and Sodium Chloride Injection

Product Name
可乐必妥
Approval Number
国药准字H20020636
Approval Date
Nov 2, 2020
NMPA

Levofloxacin and Sodium Chloride Injection

Product Name
可乐必妥
Approval Number
国药准字H20184116
Approval Date
Nov 2, 2020
NMPA

Clindamycin Hydrochloride Capsules

Product Name
盐酸克林霉素胶囊
Approval Number
国药准字H50020508
Approval Date
Jul 13, 2020
NMPA

Levofloxacin Tablets

Product Name
可乐必妥
Approval Number
国药准字H20000655
Approval Date
Mar 24, 2020
NMPA

Ofloxacin Tablets

Product Name
泰利必妥
Approval Number
国药准字H20023106
Approval Date
Mar 24, 2020
NMPA

Levofloxacin Tablets

Product Name
可乐必妥
Approval Number
国药准字H20040091
Approval Date
Mar 24, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.